A detailed history of Meadow Brook Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 26 shares of LLY stock, worth $19,961. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26
Previous 15 73.33%
Holding current value
$19,961
Previous $13.6 Million 69.6%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $8,493 - $10,560
11 Added 73.33%
26 $23 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $4,145 - $5,545
7 Added 87.5%
15 $11.7 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $4,201 - $4,953
8 New
8 $4.66 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meadow Brook Investment Advisors LLC Portfolio

Follow Meadow Brook Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meadow Brook Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meadow Brook Investment Advisors LLC with notifications on news.